- Dr Hobbs’ personal experience with diabetes
- What the approval of Fiasp® meant to him as an adult with type 1 diabetes
- How Fiasp® dose timing is different and what that means for patients with diabetes
The Vice President and Chief Medical Officer for Novo Nordisk shares his personal experience with diabetes and why Fiasp® may be an option for patients with diabetes needing mealtime insulin.
Fiasp® (insulin aspart injection) 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Please click here for Prescribing Information.